An observational study in Transfusions, Cystectomy and Blood Loss Requiring Transfusion, sponsored by Goethe University. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-02.
Sponsored by Goethe University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 151 studies in Anemia with a site in Germany — 14 open to participants now, 27 under way, 14 of them phase 3. Anemia · Germany.
Among the 151 studies in Anemia with a site in Germany, this one is the 26th largest by planned enrollment of the 31 observational ones that give a count, is one of 3 that started in 2025, is one of 31 observational ones, reaches primary completion later than 13 of the 26 other live ones, and was the 147th registered.
1,812 studies on the registry are indexed under Anemia; 212 are open to participants now.
Browse Anemia studies →14 of the 151 studies in Anemia with a site in Germany are open now. Recruiting first, the newest first:
Takeda · Sites in Germany, United States, Argentina and 28 more countries
Ages 18+
Bristol-Myers Squibb · Sites in Germany
Ages 18+
Takeda · Sites in Germany, United States, Argentina and 25 more countries
Ages 18+
iOMEDICO AG · Sites in Germany
Ages 18+
Novartis Pharmaceuticals · Sites in Germany, United States, Brazil and 3 more countries
Ages 2–18
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 117 Anemia studies recruiting now, 66 (56%) set no upper age limit and 33 (28%) stop at 75 or younger; 32 take children under 18; 21 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
151 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 30 · Phase 3 70 · Phase 4 8
First in 1996; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 270 across 368 observational studies indexed under Anemia.
Median enrollment 198 across the 120 interventional studies, 800 across the 31 observational. Of the 119 that completed or were terminated, 65 (55%) have results posted.
This tab as a report to print or save as PDF → With an account.
107 of 151 have an industry lead sponsor. The 10 most frequent:
Goethe University is the lead sponsor of 99 studies on the registry; 16 are open to participants now.
Goethe University has 2 studies filed under Anemia — fewer than ten, so there is no comparison to draw.
4 of the studies in Anemia with a site in Germany that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04747613Phase 3Novartis PharmaceuticalsLong-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria | 2027-10-18 |
| NCT05970172Phase 3Astellas Pharma Global Development, Inc.A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease | 2027-10-30 |
| NCT05146726Charite University, Berlin, GermanyPatient Blood Management Charité (PBM-Charité): Structured Detection, Differentiated Diagnostics and Therapy of Preoperative Anemia and Use of Machine Autotransfusion in Elective Interventions | 2027-02 |
| NCT07008261Goethe UniversityRobot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions. | 2027-05-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 151 studies in Anemia with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
What influence does robot-assisted surgical treatment in the sense of a radical cystectomy and possibly bladder reconstruction have on blood loss, pain and transfusion requirements? We intend to conduct a corresponding prospective observational study at a tertiary centre.
Patients with a mostly oncological indication for radical cystectomy
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Robot assistet laparoscopic cystectomy
Conventional laparotomy for cystektomie
perioperative blood loss
perioperative blood loss
Time frame: 6 hours
Preoperative iron deficiency
Preoperative messured iron deficiency
Time frame: up to 4 weeks prior surgery
RBC transfusion
Number of RBC transfusions
Time frame: perioperative up to hospital discharge or death (up to 4 weeks)
Started Aug 2025 (actual). Primary completion is estimated for May 2027, 21 months after the start.
Of 124 non-industry observational studies under Anemia, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 83. This study's planned 21 months is below that.
Counting every sponsor, half of 145 studies reached it within 30 months; a quarter within 11 and three quarters within 72.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Goethe University